Report Detail
Global Healthcare Antimicrobial Plastics Market Insights, Forecast to 2025
- RnM3539871 |
- 19 June, 2019 |
- Global |
- 129 Pages |
- QYResearch |
- Chemical & Material
Healthcare antimicrobial plastic are a type of polymer material infused with antimicrobial agents and additives such as organic-metallic biocides and arseni-based oxybisphenox arsine (OBPA). Antimicrobial plastic are mainly used to kill microorganisms such as bacteria, algae, and fungi, and inhibit their growth in the end-use products.
Global Healthcare Antimicrobial Plastics market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Healthcare Antimicrobial Plastics.
This report researches the worldwide Healthcare Antimicrobial Plastics market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Healthcare Antimicrobial Plastics breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
BASF SE (Germany)
Bayer MaterialScience AG (Germany)
The Dow Chemical Company (US)
Clariant AG (Switzerland)
Lonza Group AG (Switzerland)
Microban International (US)
Parx Plastic BV (The Netherlands)
King Plastic Corporation (US)
Biocote (UK)
Milliken Chemical (US)
Sanitized AG (Switzerland)
PolyOne Corporation (US)
Ticona Engineering Polymers (US)
DSM (Netherlands)
Doeflex-Vitapol (UK)
Healthcare Antimicrobial Plastics Breakdown Data by Type
Commodity Plastic
Engineering Plastic
High Performance Plastic
Healthcare Antimicrobial Plastics Breakdown Data by Application
Hospital
Pharmacy
Household
Medical Research
Healthcare Antimicrobial Plastics Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Healthcare Antimicrobial Plastics Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Healthcare Antimicrobial Plastics capacity, production, value, consumption, status and forecast;
To focus on the key Healthcare Antimicrobial Plastics manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Healthcare Antimicrobial Plastics :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
Global Healthcare Antimicrobial Plastics Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
- 1.1 Healthcare Antimicrobial Plastics Product
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Healthcare Antimicrobial Plastics Market Size Growth Rate by Type
- 1.4.2 Commodity Plastic
- 1.4.3 Engineering Plastic
- 1.4.4 High Performance Plastic
- 1.5 Market by Application
- 1.5.1 Global Healthcare Antimicrobial Plastics Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Pharmacy
- 1.5.4 Household
- 1.5.5 Medical Research
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Healthcare Antimicrobial Plastics Production
- 2.1.1 Global Healthcare Antimicrobial Plastics Revenue 2014-2025
- 2.1.2 Global Healthcare Antimicrobial Plastics Production 2014-2025
- 2.1.3 Global Healthcare Antimicrobial Plastics Capacity 2014-2025
- 2.1.4 Global Healthcare Antimicrobial Plastics Marketing Pricing and Trends
- 2.2 Healthcare Antimicrobial Plastics Growth Rate (CAGR) 2019-2025
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Key Healthcare Antimicrobial Plastics Manufacturers
- 2.4 Market Drivers, Trends and Issues
- 2.5 Macroscopic Indicator
- 2.5.1 GDP for Major Regions
- 2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
- 3.1 Healthcare Antimicrobial Plastics Production by Manufacturers
- 3.1.1 Healthcare Antimicrobial Plastics Production by Manufacturers
- 3.1.2 Healthcare Antimicrobial Plastics Production Market Share by Manufacturers
- 3.2 Healthcare Antimicrobial Plastics Revenue by Manufacturers
- 3.2.1 Healthcare Antimicrobial Plastics Revenue by Manufacturers (2014-2019)
- 3.2.2 Healthcare Antimicrobial Plastics Revenue Share by Manufacturers (2014-2019)
- 3.3 Healthcare Antimicrobial Plastics Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Healthcare Antimicrobial Plastics Production by Regions
- 4.1 Global Healthcare Antimicrobial Plastics Production by Regions
- 4.1.1 Global Healthcare Antimicrobial Plastics Production Market Share by Regions
- 4.1.2 Global Healthcare Antimicrobial Plastics Revenue Market Share by Regions
- 4.2 United States
- 4.2.1 United States Healthcare Antimicrobial Plastics Production
- 4.2.2 United States Healthcare Antimicrobial Plastics Revenue
- 4.2.3 Key Players in United States
- 4.2.4 United States Healthcare Antimicrobial Plastics Import & Export
- 4.3 Europe
- 4.3.1 Europe Healthcare Antimicrobial Plastics Production
- 4.3.2 Europe Healthcare Antimicrobial Plastics Revenue
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Healthcare Antimicrobial Plastics Import & Export
- 4.4 China
- 4.4.1 China Healthcare Antimicrobial Plastics Production
- 4.4.2 China Healthcare Antimicrobial Plastics Revenue
- 4.4.3 Key Players in China
- 4.4.4 China Healthcare Antimicrobial Plastics Import & Export
- 4.5 Japan
- 4.5.1 Japan Healthcare Antimicrobial Plastics Production
- 4.5.2 Japan Healthcare Antimicrobial Plastics Revenue
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Healthcare Antimicrobial Plastics Import & Export
- 4.6 Other Regions
- 4.6.1 South Korea
- 4.6.2 India
- 4.6.3 Southeast Asia
5 Healthcare Antimicrobial Plastics Consumption by Regions
- 5.1 Global Healthcare Antimicrobial Plastics Consumption by Regions
- 5.1.1 Global Healthcare Antimicrobial Plastics Consumption by Regions
- 5.1.2 Global Healthcare Antimicrobial Plastics Consumption Market Share by Regions
- 5.2 North America
- 5.2.1 North America Healthcare Antimicrobial Plastics Consumption by Application
- 5.2.2 North America Healthcare Antimicrobial Plastics Consumption by Countries
- 5.2.3 United States
- 5.2.4 Canada
- 5.2.5 Mexico
- 5.3 Europe
- 5.3.1 Europe Healthcare Antimicrobial Plastics Consumption by Application
- 5.3.2 Europe Healthcare Antimicrobial Plastics Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 UK
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Healthcare Antimicrobial Plastics Consumption by Application
- 5.4.2 Asia Pacific Healthcare Antimicrobial Plastics Consumption by Countries
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Indonesia
- 5.4.9 Thailand
- 5.4.10 Malaysia
- 5.4.11 Philippines
- 5.4.12 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Healthcare Antimicrobial Plastics Consumption by Application
- 5.5.2 Central & South America Healthcare Antimicrobial Plastics Consumption by Countries
- 5.5.3 Brazil
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Healthcare Antimicrobial Plastics Consumption by Application
- 5.6.2 Middle East and Africa Healthcare Antimicrobial Plastics Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 GCC Countries
- 5.6.5 Egypt
- 5.6.6 South Africa
6 Market Size by Type
- 6.1 Global Healthcare Antimicrobial Plastics Breakdown Dada by Type
- 6.2 Global Healthcare Antimicrobial Plastics Revenue by Type
- 6.3 Healthcare Antimicrobial Plastics Price by Type
7 Market Size by Application
- 7.1 Overview
- 7.2 Global Healthcare Antimicrobial Plastics Breakdown Dada by Application
- 7.2.1 Global Healthcare Antimicrobial Plastics Consumption by Application
- 7.2.2 Global Healthcare Antimicrobial Plastics Consumption Market Share by Application (2014-2019)
8 Manufacturers Profiles
- 8.1 BASF SE (Germany)
- 8.1.1 BASF SE (Germany) Company Details
- 8.1.2 Company Description
- 8.1.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics
- 8.1.4 Healthcare Antimicrobial Plastics Product Description
- 8.1.5 SWOT Analysis
- 8.2 Bayer MaterialScience AG (Germany)
- 8.2.1 Bayer MaterialScience AG (Germany) Company Details
- 8.2.2 Company Description
- 8.2.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics
- 8.2.4 Healthcare Antimicrobial Plastics Product Description
- 8.2.5 SWOT Analysis
- 8.3 The Dow Chemical Company (US)
- 8.3.1 The Dow Chemical Company (US) Company Details
- 8.3.2 Company Description
- 8.3.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics
- 8.3.4 Healthcare Antimicrobial Plastics Product Description
- 8.3.5 SWOT Analysis
- 8.4 Clariant AG (Switzerland)
- 8.4.1 Clariant AG (Switzerland) Company Details
- 8.4.2 Company Description
- 8.4.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics
- 8.4.4 Healthcare Antimicrobial Plastics Product Description
- 8.4.5 SWOT Analysis
- 8.5 Lonza Group AG (Switzerland)
- 8.5.1 Lonza Group AG (Switzerland) Company Details
- 8.5.2 Company Description
- 8.5.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics
- 8.5.4 Healthcare Antimicrobial Plastics Product Description
- 8.5.5 SWOT Analysis
- 8.6 Microban International (US)
- 8.6.1 Microban International (US) Company Details
- 8.6.2 Company Description
- 8.6.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics
- 8.6.4 Healthcare Antimicrobial Plastics Product Description
- 8.6.5 SWOT Analysis
- 8.7 Parx Plastic BV (The Netherlands)
- 8.7.1 Parx Plastic BV (The Netherlands) Company Details
- 8.7.2 Company Description
- 8.7.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics
- 8.7.4 Healthcare Antimicrobial Plastics Product Description
- 8.7.5 SWOT Analysis
- 8.8 King Plastic Corporation (US)
- 8.8.1 King Plastic Corporation (US) Company Details
- 8.8.2 Company Description
- 8.8.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics
- 8.8.4 Healthcare Antimicrobial Plastics Product Description
- 8.8.5 SWOT Analysis
- 8.9 Biocote (UK)
- 8.9.1 Biocote (UK) Company Details
- 8.9.2 Company Description
- 8.9.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics
- 8.9.4 Healthcare Antimicrobial Plastics Product Description
- 8.9.5 SWOT Analysis
- 8.10 Milliken Chemical (US)
- 8.10.1 Milliken Chemical (US) Company Details
- 8.10.2 Company Description
- 8.10.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics
- 8.10.4 Healthcare Antimicrobial Plastics Product Description
- 8.10.5 SWOT Analysis
- 8.11 Sanitized AG (Switzerland)
- 8.12 PolyOne Corporation (US)
- 8.13 Ticona Engineering Polymers (US)
- 8.14 DSM (Netherlands)
- 8.15 Doeflex-Vitapol (UK)
9 Production Forecasts
- 9.1 Healthcare Antimicrobial Plastics Production and Revenue Forecast
- 9.1.1 Global Healthcare Antimicrobial Plastics Production Forecast 2019-2025
- 9.1.2 Global Healthcare Antimicrobial Plastics Revenue Forecast 2019-2025
- 9.2 Healthcare Antimicrobial Plastics Production and Revenue Forecast by Regions
- 9.2.1 Global Healthcare Antimicrobial Plastics Revenue Forecast by Regions
- 9.2.2 Global Healthcare Antimicrobial Plastics Production Forecast by Regions
- 9.3 Healthcare Antimicrobial Plastics Key Producers Forecast
- 9.3.1 United States
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
- 9.4 Forecast by Type
- 9.4.1 Global Healthcare Antimicrobial Plastics Production Forecast by Type
- 9.4.2 Global Healthcare Antimicrobial Plastics Revenue Forecast by Type
10 Consumption Forecast
- 10.1 Consumption Forecast by Application
- 10.2 Healthcare Antimicrobial Plastics Consumption Forecast by Regions
- 10.3 North America Market Consumption Forecast
- 10.3.1 North America Healthcare Antimicrobial Plastics Consumption Forecast by Countries 2019-2025
- 10.3.2 United States
- 10.3.3 Canada
- 10.3.4 Mexico
- 10.4 Europe Market Consumption Forecast
- 10.4.1 Europe Healthcare Antimicrobial Plastics Consumption Forecast by Countries 2019-2025
- 10.4.2 Germany
- 10.4.3 France
- 10.4.4 UK
- 10.4.5 Italy
- 10.4.6 Russia
- 10.5 Asia Pacific Market Consumption Forecast
- 10.5.1 Asia Pacific Healthcare Antimicrobial Plastics Consumption Forecast by Countries 2019-2025
- 10.5.2 China
- 10.5.3 Japan
- 10.5.4 Korea
- 10.5.5 India
- 10.5.6 Australia
- 10.5.7 Indonesia
- 10.5.8 Thailand
- 10.5.9 Malaysia
- 10.5.10 Philippines
- 10.5.11 Vietnam
- 10.6 Central & South America Market Consumption Forecast
- 10.6.1 Central & South America Healthcare Antimicrobial Plastics Consumption Forecast by Country 2019-2025
- 10.6.2 Brazil
- 10.7 Middle East and Africa Market Consumption Forecast
- 10.7.1 Middle East and Africa Healthcare Antimicrobial Plastics Consumption Forecast by Countries 2019-2025
- 10.7.2 Middle East and Africa
- 10.7.3 Turkey
- 10.7.4 GCC Countries
- 10.7.5 Egypt
- 10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
- 11.1 Analysis of Healthcare Antimicrobial Plastics Upstream Market
- 11.1.1 Healthcare Antimicrobial Plastics Key Raw Material
- 11.1.2 Typical Suppliers of Key Healthcare Antimicrobial Plastics Raw Material
- 11.1.3 Healthcare Antimicrobial Plastics Raw Material Market Concentration Rate
- 11.2 Healthcare Antimicrobial Plastics Industry Chain Analysis
- 11.3 Marketing & Distribution
- 11.4 Healthcare Antimicrobial Plastics Distributors
- 11.5 Healthcare Antimicrobial Plastics Customers
12 Opportunities & Challenges, Threat and Affecting Factors
- 12.1 Market Opportunities
- 12.2 Market Challenges
- 12.3 Porter's Five Forces Analysis
13 Key Findings
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Healthcare Antimicrobial Plastics . Industry analysis & Market Report on Healthcare Antimicrobial Plastics is a syndicated market report, published as Global Healthcare Antimicrobial Plastics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Healthcare Antimicrobial Plastics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
